
Uncategorized - April 2, 2015
Chemo Hits Cancer Stem Cells
Researchers at the University of Bergen have conducted successful trials of a new type of chemotherapy that short-circuits cancer stem cells’ signaling system, the “command center” for the creation of new cancer cells. “In both laboratory and animal testing the drugs have shown tumors to stop growing, to be reduced or even to disappear,” said […]

Acquisition - February 9, 2015
Isofol Seeks Marketing Partner
Isofol, a clinical stage pharmaceutical company based in Gothenburg, Sweden, has launched a global program to identify one or more strategic partners for commercialization of its Modufolin(R) chemotherapy asset. The Sage Group, which is based in Europe, the USA and Asia, has been appointed by Isofol to assist the company. Sage’s job is to identify […]